Search Results

There are 15203 results for: content related to: A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome

  1. You have free access to this content
    Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 1215–1226, Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P. Garg, Paul Brunetta, Gerald Appel and LUNAR Investigator Group

    Article first published online : 27 MAR 2012, DOI: 10.1002/art.34359

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have free access to this content
    Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry

    Arthritis Care & Research

    Volume 64, Issue 3, March 2012, Pages: 331–339, X. Puéchal, J. E. Gottenberg, J. M. Berthelot, L. Gossec, O. Meyer, J. Morel, D. Wendling, M. de Bandt, E. Houvenagel, B. Jamard, T. Lequerré, G. Morel, P. Richette, J. Sellam, L. Guillevin, X. Mariette and Investigators of the Autoimmunity Rituximab Registry

    Article first published online : 28 FEB 2012, DOI: 10.1002/acr.20689

  4. You have free access to this content
    Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium

    Arthritis & Rheumatism

    Volume 63, Issue 5, May 2011, Pages: 1246–1254, I. Gutierrez-Roelens, C. Galant, I. Theate, R. J. Lories, P. Durez, A. Nzeusseu-Toukap, B. Van den Eynde, F. A. Houssiau and B. R. Lauwerys

    Article first published online : 27 APR 2011, DOI: 10.1002/art.30292

  5. You have free access to this content
    The anti-CD20 antibody rituximab reduces the Th17 cell response

    Arthritis & Rheumatism

    Volume 63, Issue 6, June 2011, Pages: 1507–1516, Frank L. van de Veerdonk, Bernard Lauwerys, Renoud J. Marijnissen, Kim Timmermans, Franco Di Padova, Marije I. Koenders, Ilse Gutierrez-Roelens, Patrick Durez, Mihai G. Netea, Jos W. M. van der Meer, Wim B. van den Berg and Leo A. B. Joosten

    Article first published online : 31 MAY 2011, DOI: 10.1002/art.30314

  6. You have free access to this content
    2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

    Arthritis Care & Research

    Volume 64, Issue 5, May 2012, Pages: 625–639, Jasvinder A. Singh, Daniel E. Furst, Aseem Bharat, Jeffrey R. Curtis, Arthur F. Kavanaugh, Joel M. Kremer, Larry W. Moreland, James O'Dell, Kevin L. Winthrop, Timothy Beukelman, S. Louis Bridges Jr., W. Winn Chatham, Harold E. Paulus, Maria Suarez-almazor, Claire Bombardier, Maxime Dougados, Dinesh Khanna, Charles M. King, Amye L. Leong, Eric L. Matteson, John T. Schousboe, Eileen Moynihan, Karen S. Kolba, Archana Jain, Elizabeth R. Volkmann, Harsh Agrawal, Sangmee Bae, Amy S. Mudano, Nivedita M. Patkar and Kenneth G. Saag

    Article first published online : 2 APR 2012, DOI: 10.1002/acr.21641

  7. Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  8. You have free access to this content
    Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

    American Journal of Transplantation

    Volume 10, Issue 1, January 2010, Pages: 89–98, N. Kamar, O. Milioto, B. Puissant-Lubrano, L. Esposito, M. C. Pierre, A. Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M. B. Nogier, D. Durand, M. Abbal, A. Blancher and L. Rostaing

    Article first published online : 28 JUL 2009, DOI: 10.1111/j.1600-6143.2009.02785.x

  9. You have free access to this content
    A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 843–853, S. De Vita, L. Quartuccio, M. Isola, C. Mazzaro, P. Scaini, M. Lenzi, M. Campanini, C. Naclerio, A. Tavoni, M. Pietrogrande, C. Ferri, M. T. Mascia, P. Masolini, A. Zabotti, M. Maset, D. Roccatello, A. L. Zignego, P. Pioltelli, A. Gabrielli, D. Filippini, O. Perrella, S. Migliaresi, M. Galli, S. Bombardieri and G. Monti

    Article first published online : 28 FEB 2012, DOI: 10.1002/art.34331

  10. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  11. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Article first published online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x

  12. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Article first published online : 9 JUN 2015, DOI: 10.1002/hon.2229

  13. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Article first published online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  14. Rituximab as maintenance therapy for patients with follicular lymphoma

    Intervention Review

    The Cochrane Library

    Liat Vidal, Anat Gafter-Gvili, Leonard Leibovici and Ofer Shpilberg

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006552.pub2

  15. You have free access to this content
    Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma

    British Journal of Clinical Pharmacology

    Volume 73, Issue 4, April 2012, Pages: 597–605, David Ternant, Guillaume Cartron, Emilie Hénin, Michel Tod, Pascal Girard and Gilles Paintaud

    Article first published online : 12 MAR 2012, DOI: 10.1111/j.1365-2125.2011.04125.x

  16. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Article first published online : 9 JUN 2015, DOI: 10.1002/hon.2228

  17. Rituximab in the treatment of autoimmune haemolytic anaemia

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 709–719, Chaturaka Rodrigo, Senaka Rajapakse and Lallindra Gooneratne

    Article first published online : 22 APR 2015, DOI: 10.1111/bcp.12498

  18. You have free access to this content
    Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

    Arthritis & Rheumatism

    Volume 65, Issue 2, February 2013, Pages: 314–324, Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Lisa G. Rider, Dana P. Ascherman, Marc C. Levesque, Richard J. Barohn, Brian M. Feldman, Michael O. Harris-Love, Diane C. Koontz, Noreen Fertig, Stephanie S. Kelley, Sherrie L. Pryber, Frederick W. Miller, Howard E. Rockette and and the RIM Study Group

    Article first published online : 28 JAN 2013, DOI: 10.1002/art.37754

  19. Experience with low-dose rituximab in off-label indications at two tertiary hospitals

    Internal Medicine Journal

    Volume 43, Issue 8, August 2013, Pages: 871–882, J. Chay, P. Donovan, L. Cummins, P. Kubler and P. Pillans

    Article first published online : 6 AUG 2013, DOI: 10.1111/imj.12207

  20. You have full text access to this Open Access content
    Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: A multicenter phase II study

    Cancer Science

    Volume 102, Issue 9, September 2011, Pages: 1698–1705, Kensei Tobinai, Tadahiko Igarashi, Kuniaki Itoh, Mitsutoshi Kurosawa, Hirokazu Nagai, Akira Hiraoka, Tomohiro Kinoshita, Naokuni Uike, Michinori Ogura, Shigeru Nawano, Shigeo Mori, Yasuo Ohashi and the IDEC-C2B8 Study Group

    Article first published online : 8 JUL 2011, DOI: 10.1111/j.1349-7006.2011.02001.x